Europe Says It Has Enough Gilead Antiviral After U.S. Push

(Bloomberg) -- Countries including Britain, Germany and Switzerland sought to allay concerns that they won’t have sufficient stocks of Gilead Sciences Inc.’s remdesivir, one of two drugs shown to t...